Landscapes / Companies
Lantern Pharma Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
1 in Phase 1
Drugs
3
in active trials
Trials
3 active
3 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
BioNumerik Pharmaceuticals |
Phase 2 | Dec 2026Phase 2 trial completes | ||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor and 5 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Nov 2028Phase 1 trial completes | |||
| Next date | 30 Nov 2028 · Phase 1 trial completes | ||||
| Also tested for | Relapsed or Refractory Lymphomas, Advanced Solid Tumor | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021